Literature DB >> 12417327

Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signalling in adult rat cardiomyocytes.

Lijun Wang1, Christopher G Proud.   

Abstract

The Gq-coupled agonists phenylephrine and endothelin-1 each activate protein synthesis in cardiomyocytes as part of the programme that leads to cardiac hypertrophy. Here we show that they each induce the dephosphorylation of elongation factor (eEF) 2, a protein that in its dephosphorylated state mediates the translocation step of elongation. The ability of both agonists to induce dephosphorylation of eEF2 requires signalling via the mTOR and MEK/Erk signalling pathways, but is independent of phosphoinositide 3-kinase. Expression of an activated form of MEK leads to dephosphorylation of eEF2, in an mTOR independent manner, indicating that signalling via MEK/Erk suffices to cause dephosphorylation of eEF2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417327     DOI: 10.1016/s0014-5793(02)03536-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

Review 1.  Molecular regulation of human skeletal muscle protein synthesis in response to exercise and nutrients: a compass for overcoming age-related anabolic resistance.

Authors:  Nathan Hodson; Daniel W D West; Andrew Philp; Nicholas A Burd; Daniel R Moore
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

2.  Effects of bisindolylmaleimide PKC inhibitors on p90RSK activity in vitro and in adult ventricular myocytes.

Authors:  Neil A Roberts; Robert S Haworth; Metin Avkiran
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

3.  Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2).

Authors:  Mark Rolfe; Laura E McLeod; Phillip F Pratt; Christopher G Proud
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

4.  Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.

Authors:  Anita Y M Chan; Vernon W Dolinsky; Carrie-Lynn M Soltys; Benoit Viollet; Shairaz Baksh; Peter E Light; Jason R B Dyck
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

5.  Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis.

Authors:  Micah J Drummond; Christopher S Fry; Erin L Glynn; Hans C Dreyer; Shaheen Dhanani; Kyle L Timmerman; Elena Volpi; Blake B Rasmussen
Journal:  J Physiol       Date:  2009-02-02       Impact factor: 5.182

6.  Regulation of RNA polymerase III transcription during hypertrophic growth.

Authors:  Sarah J Goodfellow; Fiona Innes; Louise E Derblay; W Robb MacLellan; Pamela H Scott; Robert J White
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

7.  AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.

Authors:  Ping Zhang; Xinli Hu; Xin Xu; John Fassett; Guangshuo Zhu; Benoit Viollet; Wayne Xu; Brian Wiczer; David A Bernlohr; Robert J Bache; Yingjie Chen
Journal:  Hypertension       Date:  2008-10-06       Impact factor: 10.190

8.  Lopinavir impairs protein synthesis and induces eEF2 phosphorylation via the activation of AMP-activated protein kinase.

Authors:  Ly Q Hong-Brown; C Randell Brown; Danuta S Huber; Charles H Lang
Journal:  J Cell Biochem       Date:  2008-10-15       Impact factor: 4.429

9.  A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin.

Authors:  Gareth J Browne; Christopher G Proud
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Exercise improves phosphatidylinositol-3,4,5-trisphosphate responsiveness of atypical protein kinase C and interacts with insulin signalling to peptide elongation in human skeletal muscle.

Authors:  Christian Frøsig; Mini P Sajan; Stine J Maarbjerg; Nina Brandt; Carsten Roepstorff; Jørgen F P Wojtaszewski; Bente Kiens; Robert V Farese; Erik A Richter
Journal:  J Physiol       Date:  2007-05-31       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.